See more : ROC Energy Acquisition Corp. (ROC) Income Statement Analysis – Financial Results
Complete financial analysis of Zymergen Inc. (ZY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zymergen Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- CVR Energy, Inc. (0HRR.L) Income Statement Analysis – Financial Results
- Shenzhen Refond Optoelectronics Co.,Ltd. (300241.SZ) Income Statement Analysis – Financial Results
- ENEA S.A. (ENA.WA) Income Statement Analysis – Financial Results
- DH Enchantment Inc. (ENMI) Income Statement Analysis – Financial Results
- Colt CZ Group SE (CZG.PR) Income Statement Analysis – Financial Results
Zymergen Inc. (ZY)
About Zymergen Inc.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
| Metric | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 16.74M | 13.28M | 15.42M |
| Cost of Revenue | 69.72M | 84.82M | 102.64M |
| Gross Profit | -52.98M | -71.53M | -87.22M |
| Gross Profit Ratio | -316.42% | -538.50% | -565.67% |
| Research & Development | 159.12M | 90.85M | 50.72M |
| General & Administrative | 83.01M | 60.08M | 61.25M |
| Selling & Marketing | 23.65M | 18.63M | 24.14M |
| SG&A | 106.66M | 78.70M | 85.39M |
| Other Expenses | 175.51M | 0.00 | 0.00 |
| Operating Expenses | 265.78M | 169.56M | 136.10M |
| Cost & Expenses | 335.50M | 254.37M | 238.74M |
| Interest Income | 64.00K | 492.00K | 4.92M |
| Interest Expense | 14.71M | 10.96M | 2.94M |
| Depreciation & Amortization | 20.70M | 18.71M | 15.20M |
| EBITDA | -326.33M | -232.58M | -218.65M |
| EBITDA Ratio | -1,949.08% | -1,750.80% | -1,418.08% |
| Operating Income | -347.03M | -241.09M | -237.11M |
| Operating Income Ratio | -2,072.68% | -1,814.88% | -1,537.80% |
| Total Other Income/Expenses | -14.71M | -21.15M | 318.00K |
| Income Before Tax | -361.73M | -262.24M | -236.80M |
| Income Before Tax Ratio | -2,160.51% | -1,974.13% | -1,535.74% |
| Income Tax Expense | 51.00K | -49.00K | 8.00K |
| Net Income | -361.79M | -262.19M | -236.80M |
| Net Income Ratio | -2,160.81% | -1,973.76% | -1,535.79% |
| EPS | -4.87 | -2.68 | -2.42 |
| EPS Diluted | -4.87 | -2.68 | -2.42 |
| Weighted Avg Shares Out | 74.31M | 97.94M | 97.94M |
| Weighted Avg Shares Out (Dil) | 74.31M | 97.94M | 97.94M |
ZYMERGEN INC. (ZY) CLASS ACTION LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.
New York, New York--(Newsfile Corp. - September 27, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed...
Zymergen Inc. Stock: Berger Montague Investigates Securities Fraud Claims Against Zymergen (ZY); Lead Plaintiff Deadline is October 4, 2021
Philadelphia, Pennsylvania--(Newsfile Corp. - September 27, 2021) - Berger Montague is investigating securities fraud claims against Zymergen Inc. ("Zymergen" or the "Company"). The Firm is investigating these claims on behalf of investors who purchased Zymergen securities (NASDAQ: ZY) on or...
Zymergen Inc. Stock: Berger Montague Investigates Securities Fraud Claims Against Zymergen (ZY); Lead Plaintiff Deadline is October 4, 2021
Philadelphia, Pennsylvania--(Newsfile Corp. - September 27, 2021) - Berger Montague is investigating securities fraud claims against Zymergen Inc. ("Zymergen" or the "Company"). The Firm is investigating these claims on behalf of investors who purchased Zymergen securities (NASDAQ: ZY) on or...
ZY Investor Alert: Shareholder Lawsuit Filed
Boston, Massachusetts--(Newsfile Corp. - September 26, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Zymergen Inc. (NASDAQ: ZY). The case is currently in the lead plaintiff stage....
ZY Investor Alert: Shareholder Lawsuit Filed
Boston, Massachusetts--(Newsfile Corp. - September 26, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Zymergen Inc. (NASDAQ: ZY). The case is currently in the lead plaintiff stage....
Zymergen Class Action Reminder
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 26, 2021) - Faruqi & Faruqi, LLP, a leading national securities...
Zymergen Class Action Reminder
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 26, 2021) - Faruqi & Faruqi, LLP, a leading national securities...
ROSEN, A TOP RANKED LAW FIRM, Encourages Zymergen Inc. Investors with Losses Secure Counsel Before Important October 4 Deadline in Securities Class Action - ZY
NEW YORK, Sept. 25, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration...
ZYMERGEN INC. (NASDAQ: ZY) OCTOBER 4, 2021 SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.
NEW YORK, Sept. 24, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors...
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AHCO, ZY and VIEW
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the...
Source: https://incomestatements.info
Category: Stock Reports